Quarterly rpt on consolidated results for the financial period ended 30/9/2002
| Quarterly report for the financial period ended | 30/09/2002 |
| Quarter | 3 |
| Financial Year End | 31/12/2002 |
| The figures | have not been audited |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD |
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD |
| | | |
| | | |
RM'000 | RM'000 | RM'000 | RM'000 |
| 1 | Revenue | 157,354
| 141,277
| 455,450
| 403,980
|
| 2 | Profit/(loss) before tax | 19,525
| 13,040
| 49,883
| 36,690
|
| 3 | Profit/(loss)
after tax and minority
interest | 12,073
| 7,639
| 30,562
| 22,653
|
| 4 | Net profit/(loss) for
the period | 12,073
| 7,639
| 30,562
| 22,653
|
| 5 | Basic earnings/(loss) per share (sen) | 24.10
| 15.30
| 61.10
| 45.30
|
| 6 | Dividend per share (sen) | 2.50
|
| 2.50
|
|
|
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR
END |
7
| Net tangible assets per share (RM) |
|
| 3.4500
| 3.2100
|
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA
|
| Date Announced | 22 Nov 2002 |
| Category | Financial Results |
| Reference No | CR-021122-60370 |